Rett syndrome: analysis of MECP2 and clinical characterization of 31 patients - PubMed (original) (raw)
. 2000 May 22;9(9):1369-75.
doi: 10.1093/hmg/9.9.1369.
Affiliations
- PMID: 10814718
- DOI: 10.1093/hmg/9.9.1369
Rett syndrome: analysis of MECP2 and clinical characterization of 31 patients
P Huppke et al. Hum Mol Genet. 2000.
Abstract
Only recently have mutations in MECP2 been found to be a cause of Rett Syndrome (RTT), a neuro-developmental disorder characterized by mental retardation, loss of expressive speech, deceleration of head growth and loss of acquired skills that almost exclusively affects females. We analysed the MECP2 gene in 31 patients diagnosed with RTT. Sequencing of the coding region and the splice sites revealed mutations in 24 females (77.40%). However, no abnormalities were detected in any of the parents that were available for investigation. Eleven mutations have not been described previously. Confirming two earlier studies, we found that most mutations are truncating and only a few of them are missense mutations. Several females carrying the same mutation display different phenotypes indicating that factors other than the type or position of mutations influence the severity of RTT. Four females with RTT variants were included in the study. Three of these presented with preserved speech while the fourth patient with congenital RTT lacked the initial period of normal development. Detection of mutations in these cases reveals that they are indeed variants of RTT. They represent the mild and the severe extremes of RTT.
Conclusions: mutations in MECP2 seem to be the main cause for RTT and can be expected to be found in approximately 77% of patients that fulfil the criteria for RTT. Therefore analysis of MECP2 should be performed if RTT is suspected. Three mutation hotspots (T158M, R168X and R255X) were confirmed and a further one (R270X) newly identified. We recommend screening for these mutations before analysing the coding region.
Similar articles
- [Mutation spectrum and genotype-phenotype correlation of MECP2 in patients with Rett syndrome].
Kondo I, Yamagata H. Kondo I, et al. No To Hattatsu. 2002 May;34(3):219-23. No To Hattatsu. 2002. PMID: 12030010 Japanese. - Methyl-CpG binding protein 2 gene (MECP2) variations in Japanese patients with Rett syndrome: pathological mutations and polymorphisms.
Fukuda T, Yamashita Y, Nagamitsu S, Miyamoto K, Jin JJ, Ohmori I, Ohtsuka Y, Kuwajima K, Endo S, Iwai T, Yamagata H, Tabara Y, Miki T, Matsuishi T, Kondo I. Fukuda T, et al. Brain Dev. 2005 Apr;27(3):211-7. doi: 10.1016/j.braindev.2004.06.003. Brain Dev. 2005. PMID: 15737703 - Mutational analysis of MECP2 in Japanese patients with atypical Rett syndrome.
Inui K, Akagi M, Ono J, Tsukamoto H, Shimono K, Mano T, Imai K, Yamada M, Muramatsu T, Sakai N, Okada S. Inui K, et al. Brain Dev. 2001 Jul;23(4):212-5. doi: 10.1016/s0387-7604(01)00197-8. Brain Dev. 2001. PMID: 11376998 - Rett syndrome: the complex nature of a monogenic disease.
Renieri A, Meloni I, Longo I, Ariani F, Mari F, Pescucci C, Cambi F. Renieri A, et al. J Mol Med (Berl). 2003 Jun;81(6):346-54. doi: 10.1007/s00109-003-0444-9. Epub 2003 May 16. J Mol Med (Berl). 2003. PMID: 12750821 Review. - Rett syndrome: methyl-CpG-binding protein 2 mutations and phenotype-genotype correlations.
Amir RE, Zoghbi HY. Amir RE, et al. Am J Med Genet. 2000 Summer;97(2):147-52. doi: 10.1002/1096-8628(200022)97:2<147::aid-ajmg6>3.0.co;2-o. Am J Med Genet. 2000. PMID: 11180222 Review.
Cited by
- QTc interval and ventricular action potential prolongation in the Mecp2Null/+ murine model of Rett syndrome.
Cheng H, Charles I, James AF, Abdala AP, Hancox JC. Cheng H, et al. Physiol Rep. 2022 Oct;10(19):e15437. doi: 10.14814/phy2.15437. Physiol Rep. 2022. PMID: 36200140 Free PMC article. - Delayed Ventricular Repolarization and Sodium Channel Current Modification in a Mouse Model of Rett Syndrome.
Cheng H, Charles I, James AF, Abdala AP, Hancox JC. Cheng H, et al. Int J Mol Sci. 2022 May 20;23(10):5735. doi: 10.3390/ijms23105735. Int J Mol Sci. 2022. PMID: 35628543 Free PMC article. - Analysis of X-inactivation status in a Rett syndrome natural history study cohort.
Fang X, Butler KM, Abidi F, Gass J, Beisang A, Feyma T, Ryther RC, Standridge S, Heydemann P, Jones M, Haas R, Lieberman DN, Marsh ED, Benke TA, Skinner S, Neul JL, Percy AK, Friez MJ, Caylor RC. Fang X, et al. Mol Genet Genomic Med. 2022 May;10(5):e1917. doi: 10.1002/mgg3.1917. Epub 2022 Mar 23. Mol Genet Genomic Med. 2022. PMID: 35318820 Free PMC article. - Epigenetic Mechanisms as Emerging Therapeutic Targets and Microfluidic Chips Application in Pulmonary Arterial Hypertension.
Ho L, Hossen N, Nguyen T, Vo A, Ahsan F. Ho L, et al. Biomedicines. 2022 Jan 13;10(1):170. doi: 10.3390/biomedicines10010170. Biomedicines. 2022. PMID: 35052850 Free PMC article. Review. - Modeling Rett Syndrome with Human Pluripotent Stem Cells: Mechanistic Outcomes and Future Clinical Perspectives.
Gomes AR, Fernandes TG, Cabral JMS, Diogo MM. Gomes AR, et al. Int J Mol Sci. 2021 Apr 3;22(7):3751. doi: 10.3390/ijms22073751. Int J Mol Sci. 2021. PMID: 33916879 Free PMC article. Review.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical